Moiseeva M.V., Mordyk A.V., Bagisheva N.V., Shapran A.A., Shcherbakova L.E., Mordyk D.I.
Health schools as a method of infectious disease prevention in patients with chronic somatic pathology
|
№6 / 2024
|
Ayupova K.R., Yusupova L.A.
Etiopathogenetic aspects of rosacea
|
№5 / 2024
|
Derbeneva S.A., Pogozheva A.V., Shmeleva S.V., Sabanchieva Zh.Kh.
Unifactorial prediction of the risks of development and progression of cardiovascular diseases
|
№4 / 2024
|
Leonova M.V.
Polypills in the fight against cardiovascular diseases: a modern review of effectiveness
|
№1 / 2024
|
E.A. Koltsova, E.A. Petrova, A.D. Kudryavtseva
Acquired androgen deficiency as a predictor of metabolic syndrome and ischemic stroke in men
|
№9/10 / 2023
|
D.I. Sadykova, A.A. Kamalova, R.F. Rakhmaeva, T.P. Makarova, Yu.S. Melnikova, L.F. Galimova, E.S. Slastnikova, A.A. Mustafaeva, M.A. Petrova, A.A. Garipova, Yu.A. Kalistratova, A.V. Shtyrkova, S.А. Sеnеk
Regional experience with universal screening for total cholesterol in children
|
№4-5 / 2023
|
A.V. Tarantsova
Algorithms for preventive counseling, prenosological diagnostics and self-diagnosis in the practice of a general practitioner at a Health Center
|
№10 / 2022
|
D.A. Sychev, O.D. Ostroumova, A.I. Kochetkov, A.P. Pereverzev, M.V. Klepikova, E.Yu. Ebzeeva, V.A. De
Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence
|
№3 / 2022
|
D.A. Sychev (1), O.D. Ostroumova (1), A.P. Pereverzev (1), M.S. Chernyaeva (2), A.I. Kochetkov (1), M.V. Klepikova (1), E.Yu. Ebzeeva (1), V.A. De (1)
Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions
|
№1 / 2022
|
D.A. Sychev, O.D. Ostroumova, A.P. Pereverzev, A.I. Kochetkov, M.V. Klepikova, E.Yu. Ebzeeva, V.A. De
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
|
№12 / 2021
|
D.A. Sychev (1), O.D. Ostroumova (1), M.S. Chernyaeva (2), A.P. Pereverzev (1), A.I. Kochetkov (1), T.M. Ostroumova (3), M.V. Klepikova (1), E.Yu. Ebzeeva (1), V.A. De (1)
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors
|
№11 / 2021
|
G.R. Bikbavova, M.A. Livzan, M.M. Fedorin
Prevention of colorectal cancer in patients with inflammatory bowel disease
|
№7 / 2021
|